{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:27:31Z","timestamp":1776986851458,"version":"3.51.4"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089654","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T21:43:44Z","timestamp":1393623824000},"page":"e89654","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["PPAR\u03b3 Ligands Decrease Hydrostatic Pressure-Induced Platelet Aggregation and Proinflammatory Activity"],"prefix":"10.1371","volume":"9","author":[{"given":"Fang","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Song","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11906-005-0005-4","article-title":"Is hypertension a prothrombotic state?","volume":"7","author":"GI Varughese","year":"2005","journal-title":"Curr Hypertens Rep"},{"key":"ref2","first-page":"CD003186","article-title":"Antiplatelet agents and anticoagulants for hypertension","author":"GY Lip","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.96.1.69","article-title":"Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease","volume":"96","author":"G Davi","year":"1997","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.99.19.2577","article-title":"Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb\/IIIa-dependent mechanism","volume":"99","author":"M Merten","year":"1999","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s10541-005-0184-2","article-title":"Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54","volume":"70","author":"YA Naimushin","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.smim.2009.06.004","article-title":"The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis","volume":"21","author":"D Engel","year":"2009","journal-title":"Semin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1102066","article-title":"Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L","volume":"188","author":"M Cols","year":"2012","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/art.23994","article-title":"A CD40-CD154 interaction in tissue fibrosis","volume":"58","author":"M Kawai","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2337\/db05-1673","article-title":"CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets","volume":"55","author":"FM Barbe-Tuana","year":"2006","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"V Henn","year":"1998","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.RES.0000074030.98009.FF","article-title":"CD40-CD40L and platelet function: beyond hemostasis","volume":"92","author":"JE Freedman","year":"2003","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/hc4401.099447","article-title":"Soluble CD40L and cardiovascular risk in women","volume":"104","author":"U Schonbeck","year":"2001","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1479164112455817","article-title":"CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications","volume":"10","author":"T Seijkens","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00380-010-0036-x","article-title":"Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study","volume":"26","author":"M Kayrak","year":"2011","journal-title":"Heart Vessels"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1538-7836.2010.04176.x","article-title":"Microvascular thrombosis and CD40\/CD40L signaling","volume":"9","author":"FN Gavins","year":"2011","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.cellbio.12.1.335","article-title":"Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology","volume":"12","author":"T Lemberger","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"M Ricote","year":"1998","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"C Jiang","year":"1998","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2004-03-0926","article-title":"Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes","volume":"104","author":"F Akbiyik","year":"2004","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1160\/TH07-05-0328","article-title":"Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles","volume":"99","author":"DM Ray","year":"2008","journal-title":"Thromb Haemost"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/07853890410017386","article-title":"Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy","volume":"36","author":"S Nadar","year":"2004","journal-title":"Ann Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/1381612033454559","article-title":"The prothrombotic state in hypertension and the effects of antihypertensive treatment","volume":"9","author":"S Nadar","year":"2003","journal-title":"Curr Pharm Des"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.jhh.1001044","article-title":"Hypertension and the heart","volume":"14","author":"RE Schmieder","year":"2000","journal-title":"J Hum Hypertens"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin\u2013dependent mechanism","volume":"8","author":"P Andre","year":"2002","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMe030012","article-title":"CD40 ligand\u2013assessing risk instead of damage?","volume":"348","author":"JE Freedman","year":"2003","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"C Heeschen","year":"2003","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0958-1669(99)00030-0","article-title":"Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions","volume":"10","author":"L Michalik","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"N Marx","year":"1998","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","article-title":"Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets","volume":"122","author":"MM Denis","year":"2005","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187152512800388948","article-title":"PPAR- \u03b3 agonist in treatment of diabetes: cardiovascular safety considerations","volume":"10","author":"A Abbas","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:20:39Z","timestamp":1565230839000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089654"}},"subtitle":[],"editor":[{"given":"You-Yang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089654","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}